Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.

Ana Carolina PavanelliFlavia Rotea MangonePiriya YoganathanSimone Aparecida BessaSuely NonogakiCynthia A B de Toledo OsórioVictor Piana de AndradeIberê Cauduro SoaresEvandro Sobrosa de MelloLois M MulliganMaria Aparecida Nagai

Published in: Breast cancer research and treatment (2022)

Our findings suggest RET, BCAR1, and BCAR3 as potential candidate markers for endocrine therapy resistance in Luminal BC.

Keyphrases

poor prognosis
binding protein
climate change
mesenchymal stem cells
long non coding rna
cell therapy
smoking cessation